2nd Quarter - Report — PREVENT BLINDNESS for PREVENT BLINDNESS (2008)

Firm

PREVENT BLINDNESS

Client

PREVENT BLINDNESS

Income

—

Expenses

$45,285

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General research and prevention health appropriations.

Lobbyist	Covered position, as disclosed
DANIEL GARRETT	—

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.